U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H15F2N3O3S
Molecular Weight 331.338
Optical Activity ( + )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GENACONAZOLE, (R,R)-

SMILES

C[C@H]([C@](O)(CN1C=NC=N1)C2=CC=C(F)C=C2F)S(C)(=O)=O

InChI

InChIKey=HFGZFHCWKKQGIS-NOZJJQNGSA-N
InChI=1S/C13H15F2N3O3S/c1-9(22(2,20)21)13(19,6-18-8-16-7-17-18)11-4-3-10(14)5-12(11)15/h3-5,7-9,19H,6H2,1-2H3/t9-,13-/m1/s1

HIDE SMILES / InChI

Molecular Formula C13H15F2N3O3S
Molecular Weight 331.338
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Sch 39304 is a new broad-spectrum orally active triazole antifungal agent that is active, orally and topically, against a broad range of fungal pathogens, including superficial Trichophyton mentagrophytes and vaginal Candida albicans infections. The mechanism of action of SCH-39304 appears similar to those of ketoconazole and fluconazole, involving inhibition of cell membrane ergosterol synthesis. SCH-39304 has two asymmetrical carbon atoms, and the formulation used in clinical trials has been a racemic mixture of two enantiomers, active SCH-42427 (RR (+)-) and inactive SCH-424264 (SS (–)-). Unfortunately, hepatocarcinomas associated with the use of SCH-39304 in animals have sharply restricted the development and use of this agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
Stereoselective interaction of the azole antifungal agent SCH39304 with the cytochrome P-450 monooxygenase system isolated from Cryptococcus neoformans.
1997-07
Synthesis and antifungal activity of alkylthio and alkylsulfonyl derivatives of SM-8668.
1996-02
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
1995-06
Pneumocystis carinii is resistant to imidazole antifungal agents.
1994-08
Ro 09-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi.
1993-12
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
1992-05
Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.
1992-01
Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination.
1991-09
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
1990-08

Sample Use Guides

200 mg once daily for 12 weeks
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:03:57 GMT 2025
Edited
by admin
on Mon Mar 31 18:03:57 GMT 2025
Record UNII
I87RHM3O1J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SCH-39304, (+)-
Preferred Name English
GENACONAZOLE, (R,R)-
Common Name English
1H-1,2,4-TRIAZOLE-1-ETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-.ALPHA.-((1R)-1-(METHYLSULFONYL)ETHYL)-, (.ALPHA.R)-
Systematic Name English
(.ALPHA.R)-.ALPHA.-(2,4-DIFLUOROPHENYL)-.ALPHA.-((1R)-1-(METHYLSULFONYL)ETHYL)-1H-1,2,4-TRIAZOLE-1-ETHANOL
Common Name English
SCH-39304, (R,R)-
Code English
SCH-42427
Code English
SM-9164
Code English
1H-1,2,4-TRIAZOLE-1-ETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-.ALPHA.-(1-(METHYLSULFONYL)ETHYL)-, (R-(R*,R*))-
Common Name English
SM1964
Code English
SCH42427
Code English
Code System Code Type Description
FDA UNII
I87RHM3O1J
Created by admin on Mon Mar 31 18:03:57 GMT 2025 , Edited by admin on Mon Mar 31 18:03:57 GMT 2025
PRIMARY
PUBCHEM
452261
Created by admin on Mon Mar 31 18:03:57 GMT 2025 , Edited by admin on Mon Mar 31 18:03:57 GMT 2025
PRIMARY
CAS
121650-83-7
Created by admin on Mon Mar 31 18:03:57 GMT 2025 , Edited by admin on Mon Mar 31 18:03:57 GMT 2025
PRIMARY
EPA CompTox
DTXSID90923916
Created by admin on Mon Mar 31 18:03:57 GMT 2025 , Edited by admin on Mon Mar 31 18:03:57 GMT 2025
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER